{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:58:53Z","timestamp":1783349933043,"version":"3.54.6"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274566"],"award-info":[{"award-number":["82274566"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-025-01872-3","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T05:36:32Z","timestamp":1765344992000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MAPK signaling reprogramming via integrative TCM-Western medicine strategy: mechanistic interactions between bioactive herbal components and chemotherapy in ovarian cancer therapy \u2014 a comprehensive review"],"prefix":"10.1186","volume":"19","author":[{"given":"Shiwen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"issue":"1","key":"1872_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"1872_CR2","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1021\/cr000241p","volume":"101","author":"Z Chen","year":"2001","unstructured":"Chen Z, Gibson TB, Robinson F, et al. MAP kinases. Chem Rev. 2001;101(8):2449\u201376. https:\/\/doi.org\/10.1021\/cr000241p.","journal-title":"Chem Rev"},{"issue":"18","key":"1872_CR3","first-page":"260","volume":"30","author":"X Zheng","year":"2024","unstructured":"Zheng X, Shu Z, Yi L, Qu Z, Li W, Ma K, et al. Traditional Chinese medicine regulates oxidative stress-related signaling pathways to prevent and treat bronchial asthma: a review. Chin J Exp Tradit Med Formulae. 2024;30(18):260\u20139.","journal-title":"Chin J Exp Tradit Med Formulae"},{"issue":"22","key":"1872_CR4","doi-asserted-by":"publisher","first-page":"R886","DOI":"10.1016\/j.cub.2003.10.053","volume":"13","author":"M Raman","year":"2003","unstructured":"Raman M, Cobb MH. MAP kinase modules: many roads home. Curr Biol. 2003;13(22):R886\u20138. https:\/\/doi.org\/10.1016\/j.cub.2003.10.053.","journal-title":"Curr Biol"},{"key":"1872_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semcancer.2021.05.010","volume":"85","author":"R Ullah","year":"2022","unstructured":"Ullah R, Yin Q, Snell AH, Wan L. RAF-MEK-ERK pathway in cancer evolution and treatment. Semin Cancer Biol. 2022;85:123\u201354. https:\/\/doi.org\/10.1016\/j.semcancer.2021.05.010.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"1872_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03024-2","volume":"9","author":"B Yang","year":"2018","unstructured":"Yang B, Li M, Tang W, et al. Dynamic network biomarker indicates pulmonary metastasis at the tipping point of hepatocellular carcinoma. Nat Commun. 2018;9(1):678. https:\/\/doi.org\/10.1038\/s41467-018-03024-2.","journal-title":"Nat Commun"},{"issue":"10","key":"1872_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8101658","volume":"8","author":"M Teeuwssen","year":"2019","unstructured":"Teeuwssen M, Fodde R. Wnt signaling in ovarian cancer stemness, EMT, and therapy resistance. J Clin Med. 2019;8(10):1658. https:\/\/doi.org\/10.3390\/jcm8101658.","journal-title":"J Clin Med"},{"key":"1872_CR8","doi-asserted-by":"publisher","first-page":"106656","DOI":"10.1016\/j.phrs.2022.106656","volume":"188","author":"X Wang","year":"2023","unstructured":"Wang X, Zhang Y, Li J, et al. Spatiotemporal regulation of Curcumin on MAPK oscillatory dynamics in chemoresistant ovarian cancer. Pharmacol Res. 2023;188:106656. https:\/\/doi.org\/10.1016\/j.phrs.2022.106656.","journal-title":"Pharmacol Res"},{"issue":"20","key":"1872_CR9","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1158\/0008-5472.CAN-22-0123","volume":"82","author":"Y Liu","year":"2022","unstructured":"Liu Y, Wang Y, Liu J, et al. Network entropy rewiring by Celastrol overcomes chemoresistance through PPAR\u03b3-mediated ferroptosis. Cancer Res. 2022;82(20):3772\u201385. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-0123.","journal-title":"Cancer Res"},{"issue":"2","key":"1872_CR10","first-page":"414","volume":"47","author":"BC Behrens","year":"1987","unstructured":"Behrens BC, Hamilton TC, Masuda H, et al. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res. 1987;47(2):414\u20138.","journal-title":"Cancer Res"},{"key":"1872_CR11","first-page":"15","volume":"57","author":"G Chu","year":"1997","unstructured":"Chu G, Mantin R, Shen YM, et al. Massive cisplatin overdose by accidental substitution for carboplatin: toxicity and management. Cancer Res. 1997;57:15\u20137.","journal-title":"Cancer Res"},{"issue":"3","key":"1872_CR12","first-page":"285","volume":"11","author":"TC Hamilton","year":"1984","unstructured":"Hamilton TC, Young RC, Ozols RF. Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches. Semin Oncol. 1984;11(3):285\u201398.","journal-title":"Semin Oncol"},{"key":"1872_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/978-1-4757-1647-4_5","volume-title":"Human Tumor Cells In Vitro","author":"J Fogh","year":"1975","unstructured":"Fogh J, Trempe G. New human tumor cell lines. In: Fogh J, editor. Human Tumor Cells In Vitro. Plenum; 1975. p. 115\u201359."},{"issue":"19","key":"1872_CR14","first-page":"5181","volume":"51","author":"DH Lau","year":"1991","unstructured":"Lau DH, Lewis AD, Ehsan MN, Sikic BI. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin. Cancer Res. 1991;51(19):5181\u20137.","journal-title":"Cancer Res"},{"issue":"5","key":"1872_CR15","first-page":"289","volume":"20","author":"JH Chen","year":"1985","unstructured":"Chen JH, Hua R, Wang XJ. [Establishment of a human ovarian serous cystadenocarcinoma cell line (HO-8910) and its biological characteristics] [in Chinese]. Chin J Obstet Gynecol. 1985;20(5):289\u201391.","journal-title":"Chin J Obstet Gynecol"},{"issue":"4","key":"1872_CR16","first-page":"1703","volume":"43","author":"SC Barranco","year":"1983","unstructured":"Barranco SC, Townsend CM Jr, Casartelli C, et al. Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res. 1983;43(4):1703\u20139.","journal-title":"Cancer Res"},{"issue":"11","key":"1872_CR17","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1530\/ERC-22-0096","volume":"29","author":"F Morin","year":"2022","unstructured":"Morin F, Koustova A, Gonen N, et al. The MAPK pathway interacts with the FOXL2 C134W mutation to promote granulosa cell tumor development. Endocr Relat Cancer. 2022;29(11):599\u2013613. https:\/\/doi.org\/10.1530\/ERC-22-0096.","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"1872_CR18","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3760\/cma.j.issn.0529-567x.2019.08.007","volume":"54","author":"XL Jiang","year":"2019","unstructured":"Jiang XL, Gao JC, Jiang L, et al. Zhonghua Fu Chan Ke Za Zhi. 2019;54(8):541\u20137. https:\/\/doi.org\/10.3760\/cma.j.issn.0529-567x.2019.08.007.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"7","key":"1872_CR19","doi-asserted-by":"publisher","first-page":"593","DOI":"10.4155\/fmc-2019-0339","volume":"12","author":"S Pathania","year":"2020","unstructured":"Pathania S, Rawal RK. An update on chemical classes targeting ERK1\/2 for the management of cancer. Future Med Chem. 2020;12(7):593\u2013611. https:\/\/doi.org\/10.4155\/fmc-2019-0339.","journal-title":"Future Med Chem"},{"issue":"1","key":"1872_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11551","volume":"7","author":"PR de Jong","year":"2016","unstructured":"de Jong PR, Taniguchi K, Harris AR, et al. Erk5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon Erk1\/2 abrogation. Nat Commun. 2016;7(1):11551. https:\/\/doi.org\/10.1038\/ncomms11551.","journal-title":"Nat Commun"},{"key":"1872_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.phrs.2019.01.039","volume":"142","author":"R Roskoski Jr.","year":"2019","unstructured":"Roskoski R Jr. Targeting ERK1\/2 protein-serine\/threonine kinases in human cancers. Pharmacol Res. 2019;142:151\u201368. https:\/\/doi.org\/10.1016\/j.phrs.2019.01.039.","journal-title":"Pharmacol Res"},{"issue":"51","key":"1872_CR22","first-page":"7746","volume":"20","author":"YP Tang","year":"2016","unstructured":"Tang YP, Liu Q, Guo CW, Xie RD. Periodontitis and p38 mitogen activated protein kinase pathway: research and development. Chin J Tissue Eng Res. 2016;20(51):7746.","journal-title":"Chin J Tissue Eng Res"},{"issue":"5","key":"1872_CR23","first-page":"494","volume":"44","author":"L Ling","year":"2017","unstructured":"Ling L, Qi Z, Li Z. Progress of relationship between p38MAPK pathway and ovarian carcinoma. J Int Obstet Gynecol. 2017;44(5):494.","journal-title":"J Int Obstet Gynecol"},{"issue":"9\u201310","key":"1872_CR24","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1177\/1947601913507951","volume":"4","author":"HK Koul","year":"2013","unstructured":"Koul HK, Pal M, Koul S. Role of p38 MAP kinase signal transduction in solid tumors. Genes Cancer. 2013;4(9\u201310):342\u201359. https:\/\/doi.org\/10.1177\/1947601913507951.","journal-title":"Genes Cancer"},{"issue":"8","key":"1872_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13438","volume":"56","author":"ZW Shi","year":"2023","unstructured":"Shi ZW, Zhu L, Song ZR, Liu TJ, Hao DJ. Roles of p38 MAPK signalling in intervertebral disc degeneration. Cell Prolif. 2023;56(8):e13438. https:\/\/doi.org\/10.1111\/cpr.13438.","journal-title":"Cell Prolif"},{"issue":"2","key":"1872_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ccr.2007.01.009","volume":"11","author":"NJ Kennedy","year":"2007","unstructured":"Kennedy NJ, Cellurale C, Davis RJ. A radical role for p38 MAPK in tumor initiation. Cancer Cell. 2007;11(2):101\u20133. https:\/\/doi.org\/10.1016\/j.ccr.2007.01.009.","journal-title":"Cancer Cell"},{"issue":"8","key":"1872_CR27","first-page":"572","volume":"25","author":"CH Zou","year":"2015","unstructured":"Zou CH, Wang H, Song DD. Correlation between P38 mitogen-activated protein kinase signal transduction pathway and uPA expression in ovarian cancer. Chin J Cancer. 2015;25(8):572\u20138.","journal-title":"Chin J Cancer"},{"issue":"1","key":"1872_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10585-019-09993-y","volume":"37","author":"H Yasui","year":"2020","unstructured":"Yasui H, Kajiyama H, Tamauchi S, et al. CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway. Clin Exp Metastasis. 2020;37(1):145\u201358. https:\/\/doi.org\/10.1007\/s10585-019-09993-y.","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"1872_CR29","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s10753-014-0033-9","volume":"38","author":"W Du","year":"2015","unstructured":"Du W, Wu PF, Qing LM, et al. Systemic and flap inflammatory response associates with thrombosis in flap venous crisis. Inflammation. 2015;38(1):298\u2013304. https:\/\/doi.org\/10.1007\/s10753-014-0033-9.","journal-title":"Inflammation"},{"issue":"12","key":"1872_CR30","first-page":"943","volume":"25","author":"TH Xie","year":"2017","unstructured":"Xie TH, Chen RH, Mao TY, et al. Yinchen and Erchen detection ameliorates non-alcoholic steatohepatitis by regulating JNK1 and AP-1 protein expression. Chin J Integr Med Dig. 2017;25(12):943\u20137.","journal-title":"Chin J Integr Med Dig"},{"issue":"11","key":"1872_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113657","volume":"19","author":"S Win","year":"2018","unstructured":"Win S, Than TA, Kaplowitz N. The regulation of JNK signaling pathways in cell death through the interplay with mitochondrial SAB and upstream post-translational effects. Int J Mol Sci. 2018;19(11):3657. https:\/\/doi.org\/10.3390\/ijms19113657.","journal-title":"Int J Mol Sci"},{"key":"1872_CR32","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/B978-0-323-99535-1.00019-6","volume-title":"Zero-Dimensional Carbon Nanomaterials","author":"MHM Zaid","year":"2024","unstructured":"Zaid MHM, Abd Manan FA, Bakhori NM, et al. Biocompatibility and cytotoxicity studies of zero-dimensional carbon nanomaterials. In: Tiwari A, et al., editors. Zero-Dimensional Carbon Nanomaterials. Woodhead Publishing; 2024. p. 611\u201340."},{"issue":"3","key":"1872_CR33","first-page":"325","volume":"30","author":"YB Zhang","year":"2010","unstructured":"Zhang YB, Sun BL, Yuan H, Yang MF, Niu JZ, Lv GW. Mitogen-activated protein kinases and morphine tolerance [in Chinese]. Basic Clin Med. 2010;30(3):325.","journal-title":"Basic Clin Med"},{"issue":"24","key":"1872_CR34","first-page":"205","volume":"17","author":"ZD Hong","year":"2011","unstructured":"Hong ZD, Mo ZX. Kinds of signal pathways in anti-tumor mechanism of traditional Chinese medicine [in Chinese]. Chin J Exp Tradit Med Form. 2011;17(24):205\u201318.","journal-title":"Chin J Exp Tradit Med Form"},{"issue":"3","key":"1872_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2022.119418","volume":"1870","author":"J Yang","year":"2023","unstructured":"Yang J, Wang J, Zhang Y, et al. C-Jun phosphorylated by JNK is required for protecting Gli2 from proteasomal-ubiquitin degradation by PGE2-JNK signaling axis. Biochimica et Biophysica Acta (BBA). 2023;1870(3):119418. https:\/\/doi.org\/10.1016\/j.bbamcr.2022.119418.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"7","key":"1872_CR36","first-page":"1096","volume":"46","author":"HY Liu","year":"2015","unstructured":"Liu HY. Research progress on Chinese materia medica for reversing tumor multidrug resistance [in Chinese]. Chin Tradit Herb Drugs. 2015;46(7):1096\u2013102.","journal-title":"Chin Tradit Herb Drugs"},{"issue":"24","key":"1872_CR37","first-page":"1518","volume":"40","author":"Y Fu","year":"2013","unstructured":"Fu Y, Han X, Li Y. Inhibition of the JNK pathway downregulates lung-resistance protein and enhances the chemosensitivity of A549 cells to cisplatin [in Chinese]. Chin J Clin Oncol. 2013;40(24):1518\u201322.","journal-title":"Chin J Clin Oncol"},{"key":"1872_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.975197","volume":"13","author":"N Grave","year":"2022","unstructured":"Grave N, Scheffel TB, Cruz FF, et al. The functional role of p38 MAPK pathway in malignant brain tumors. Front Pharmacol. 2022;13:975197. https:\/\/doi.org\/10.3389\/fphar.2022.975197.","journal-title":"Front Pharmacol"},{"issue":"suppl 2","key":"1872_CR39","first-page":"163","volume":"34","author":"Y Li","year":"2022","unstructured":"Li Y, Liu J. Research advances on antitumor effect of myricetin and Dihydromyricetin [in Chinese]. Nat Prod Res Dev. 2022;34(suppl 2):163.","journal-title":"Nat Prod Res Dev"},{"issue":"9","key":"1872_CR40","first-page":"2061","volume":"55","author":"FJ Wang","year":"2020","unstructured":"Wang FJ, Wang HJ, Chen XB, Yi YF, Xie Y, Zhang T. Dihydromyricetin promotes cell apoptosis through activating Endoplasmic reticulum stress in ovarian cancer A2780 cells [in Chinese]. Acta Pharm Sin. 2020;55(9):2061\u20136.","journal-title":"Acta Pharm Sin"},{"issue":"2","key":"1872_CR41","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00044-013-0711-4","volume":"23","author":"Y Liu","year":"2014","unstructured":"Liu Y, Song X, He J, Zheng X, Wu H. Synthetic derivatives of Chrysin and their biological activities. Med Chem Res. 2014;23(2):555\u201363.","journal-title":"Med Chem Res"},{"issue":"5","key":"1872_CR42","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0960-894X(02)01081-8","volume":"13","author":"X Zheng","year":"2003","unstructured":"Zheng X, Meng WD, Xu YY, Cao JG, Qing FL. Synthesis and anticancer effect of Chrysin derivatives. Bioorg Med Chem Lett. 2003;13(5):881\u20134.","journal-title":"Bioorg Med Chem Lett"},{"issue":"20","key":"1872_CR43","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.2174\/0109298673282376231218060431","volume":"31","author":"S Zaib","year":"2024","unstructured":"Zaib S, Javed H, Rana N, Zaib Z, Iqbal S, Khan I. Therapeutic chemoresistance in ovarian cancer: emerging hallmarks, signaling mechanisms and alternative pathways. Curr Med Chem. 2024;31(20):2883\u2013906. https:\/\/doi.org\/10.2174\/0109298673282376231218060431.","journal-title":"Curr Med Chem"},{"issue":"1","key":"1872_CR44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.14712\/fb2020066010036","volume":"66","author":"AF El-Kott","year":"2020","unstructured":"El-Kott AF, Shati AA, Al-Kahtani MA, Alharbi SA. Kaempferol induces cell death in A2780 ovarian cancer cells and increases their sensitivity to cisplatin by activation of cytotoxic endoplasmic reticulum-mediated autophagy and inhibition of protein kinase B. Folia Biol (Praha). 2020;66(1):36\u201346. https:\/\/doi.org\/10.14712\/fb2020066010036.","journal-title":"Folia Biol (Praha)"},{"key":"1872_CR45","doi-asserted-by":"publisher","first-page":"5096","DOI":"10.12659\/msm.903552","volume":"23","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Tian B, Wang Y, Ding H. Kaempferol sensitizes human ovarian cancer cells-OVCAR-3 and SKOV-3 to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis via JNK\/ERK-CHOP pathway and up-regulation of death receptors 4 and 5. Med Sci Monit. 2017;23:5096\u2013105. https:\/\/doi.org\/10.12659\/msm.903552.","journal-title":"Med Sci Monit"},{"issue":"6","key":"1872_CR46","doi-asserted-by":"publisher","first-page":"9756","DOI":"10.1002\/jcb.28259","volume":"120","author":"Y Tang","year":"2019","unstructured":"Tang Y, Li X, Liu Z, Simoneau AR, Xie J, Zi X. Tangeretin inhibits ovarian cancer progression through Wnt\/\u03b2-catenin signaling. J Cell Biochem. 2019;120(6):9756\u201365. https:\/\/doi.org\/10.1002\/jcb.28259.","journal-title":"J Cell Biochem"},{"key":"1872_CR47","doi-asserted-by":"publisher","unstructured":"Li X, Xu Z, Wang L, et al. Hydroxysafflor yellow A ameliorates adenomyosis by improving IDH1-autophagy-EMT [preprint online]. Authorea November. 2023;21. https:\/\/doi.org\/10.22541\/au.170056440.09990215\/v1. Accessed.","DOI":"10.22541\/au.170056440.09990215\/v1"},{"issue":"1","key":"1872_CR48","doi-asserted-by":"publisher","first-page":"2108557","DOI":"10.1155\/2022\/2108557","volume":"2022","author":"Y Chen","year":"2022","unstructured":"Chen Y, Li M, Wen J, Pan X, Deng Z, Chen J, et al. Pharmacological activities of safflower yellow and its clinical applications. Evid Based Complement Alternat Med. 2022;2022(1):2108557. https:\/\/doi.org\/10.1155\/2022\/2108557.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1872_CR49","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.eujim.2018.11.006","volume":"25","author":"YC Ma","year":"2019","unstructured":"Ma YC, Li MM, Wu Q, et al. Hydroxysafflor yellow A sensitizes ovarian cancer cells to chemotherapeutic agent by decreasing WSB1 expression. Eur J Integr Med. 2019;25:6\u201312. https:\/\/doi.org\/10.1016\/j.eujim.2018.11.006.","journal-title":"Eur J Integr Med"},{"key":"1872_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154846","volume":"116","author":"L Wu","year":"2023","unstructured":"Wu L, Qian C, Zhang W, Shi M, Chen X, Wang Y, et al. Ginkgetin suppresses ovarian cancer growth through inhibition of JAK2\/STAT3 and MAPKs signaling pathways. Phytomedicine. 2023;116:154846. https:\/\/doi.org\/10.1016\/j.phymed.2023.154846.","journal-title":"Phytomedicine"},{"issue":"3","key":"1872_CR51","first-page":"321","volume":"115","author":"X Wen","year":"2024","unstructured":"Wen X, Li Y, Zhang J, et al. Dual regulatory effects of Curcumin on Ras\/ERK signaling in gastric adenocarcinoma cells. J Cell Biochem. 2024;115(3):321\u201335.","journal-title":"J Cell Biochem"},{"key":"1872_CR52","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.phymed.2018.06.044","volume":"55","author":"C Wang","year":"2019","unstructured":"Wang C, Liu R, Zhao H, et al. Naringin suppresses ovarian cancer progression through coordinated modulation of p38 MAPK and ERK1\/2 pathways. Phytomedicine. 2019;55:238\u201347.","journal-title":"Phytomedicine"},{"issue":"2","key":"1872_CR53","first-page":"225","volume":"375","author":"M Shan","year":"2016","unstructured":"Shan M, Zhang Y, Wang C, et al. Mechanistic insights into phytochemical-mediated modulation of MAPK signaling in ovarian cancer. Cancer Lett. 2016;375(2):225\u201333.","journal-title":"Cancer Lett"},{"issue":"8","key":"1872_CR54","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1002\/ptr.7118","volume":"35","author":"H Jiang","year":"2021","unstructured":"Jiang H, Liu T, Zhao R. Gentiopicroside suppresses ovarian cancer progression via p38 MAPK-mediated apoptosis. Phytother Res. 2021;35(8):4321\u201332. https:\/\/doi.org\/10.1002\/ptr.7118.","journal-title":"Phytother Res"},{"key":"1872_CR55","volume":"117","author":"J Li","year":"2019","unstructured":"Li J, Wang F, Zhang K. Gentiopicroside regulates Bax\/Bcl-2 to promote apoptosis in ovarian cancer cells. Biomed Pharmacother. 2019;117:109123.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"1872_CR56","first-page":"3456","volume":"236","author":"Y Gao","year":"2021","unstructured":"Gao Y, Chen X, Zhang L. Triptolide induces apoptosis in ovarian cancer cells via ROS-mediated MAPK activation. J Cell Physiol. 2021;236(5):3456\u201367.","journal-title":"J Cell Physiol"},{"issue":"3","key":"1872_CR57","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3892\/ijo.2017.3869","volume":"50","author":"J Ru","year":"2017","unstructured":"Ru J, Zhang Y, Chen H. Triptolide inhibits the growth and metastasis of ovarian cancer cells by inactivating the MAPK signaling pathway. Int J Oncol. 2017;50(3):956\u201364. https:\/\/doi.org\/10.3892\/ijo.2017.3869.","journal-title":"Int J Oncol"},{"key":"1872_CR58","doi-asserted-by":"publisher","unstructured":"Agrawal KK, Murti Y. A systematic review on anticancer potential of traditional Chinese medicine (Yang Zheng XiaoJi). Pharmacol Res - Mod Chin Med. 2024;100505. https:\/\/doi.org\/10.1016\/j.phymed.2024.100505.","DOI":"10.1016\/j.phymed.2024.100505"},{"issue":"2","key":"1872_CR59","first-page":"344","volume":"43","author":"SL He","year":"2021","unstructured":"He SL, Luo Y. Effects of active components of ardisia gigantifolia on DUSPs\/MAPK signaling pathway in HepG2 cells [in Chinese]. Chin Tradit Pat Med. 2021;43(2):344\u20139.","journal-title":"Chin Tradit Pat Med"},{"key":"1872_CR60","doi-asserted-by":"crossref","unstructured":"Tao X, Yin L, Xu L, Peng J. Dioscin: A diverse acting natural compound with therapeutic potential in metabolic diseases, cancer, inflammation and infections. Pharmacol Res. 2018;137:259-269. doi:10.1016\/j.phrs.2018.09.022","DOI":"10.1016\/j.phrs.2018.09.022"},{"key":"1872_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.698424","volume":"12","author":"J Kuai","year":"2021","unstructured":"Kuai J, Han C, Wei W. Potential regulatory roles of GRK2 in endothelial cell activity and pathological angiogenesis. Front Immunol. 2021;12:698424. https:\/\/doi.org\/10.3389\/fimmu.2021.698424.","journal-title":"Front Immunol"},{"issue":"1","key":"1872_CR62","first-page":"35","volume":"31","author":"S Chen","year":"2021","unstructured":"Chen S, Hua R, Zhang W, Li X, Chen H, Xu R. miR-122-5p inhibits the growth of esophageal cancer cells and transplanted tumors by targeting CREB1. China Oncol. 2021;31(1):35\u201344.","journal-title":"China Oncol"},{"issue":"11","key":"1872_CR63","first-page":"800","volume":"22","author":"DR Liu","year":"2020","unstructured":"Liu DR, Li BZ. Research progress in caspase family of apoptosis core gene [in Chinese]. Chin J Med Guide. 2020;22(11):800\u20135.","journal-title":"Chin J Med Guide"},{"issue":"5","key":"1872_CR64","first-page":"102","volume":"41","author":"Y Guo","year":"2020","unstructured":"Guo Y, Yang X, Li Y. Alkylresorcinols from wheat bran induced autophagy and apoptosis of HepG2 cells. Food Sci. 2020;41(5):102\u20137.","journal-title":"Food Sci"},{"issue":"14","key":"1872_CR65","first-page":"1728","volume":"35","author":"L Zhu","year":"2019","unstructured":"Zhu L, Duan S, Qin H, Zhang X, Zhao S, Li S, et al. Effect of Protodioscin on cell proliferation, apoptosis and invasion of ovarian cancer cell SKOV3 through regulating JNK\/P38 MAPK signal pathway [in Chinese]. Chin J Immunol. 2019;35(14):1728\u201334.","journal-title":"Chin J Immunol"},{"key":"1872_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2019.108936","volume":"316","author":"Y Tian","year":"2020","unstructured":"Tian Y, Gong GY, Ma LL, Wang ZQ, Song D, Fang MY. Anti-cancer effects of polyphyllin I: an update in 5 years. Chem Biol Interact. 2020;316:108936. https:\/\/doi.org\/10.1016\/j.cbi.2019.108936.","journal-title":"Chem Biol Interact"},{"issue":"2","key":"1872_CR67","first-page":"163","volume":"40","author":"X Liu","year":"2020","unstructured":"Liu X. Polyphyllin I directly targets stat3 to inhibit proliferation of glioma U251 cells and induce apoptosis [in Chinese]. Tumor. 2020;40(2):163\u201371.","journal-title":"Tumor"},{"issue":"3","key":"1872_CR68","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/s0254-6272(13)60174-0","volume":"33","author":"L Gu","year":"2013","unstructured":"Gu L, Feng J, Xu H, Luo M, Su D. Polyphyllin i inhibits proliferation and metastasis of ovarian cancer cell line HO-8910PM in vitro. J Tradit Chin Med. 2013;33(3):325\u201333. https:\/\/doi.org\/10.1016\/s0254-6272(13)60174-0.","journal-title":"J Tradit Chin Med"},{"issue":"1","key":"1872_CR69","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.phymed.2015.12.003","volume":"23","author":"TC Chen","year":"2016","unstructured":"Chen TC, Chien CC, Wu MS, Chen YC. Evodiamine from Evodia rutaecarpa induces apoptosis via activation of JNK and PERK in human ovarian cancer cells. Phytomedicine. 2016;23(1):68\u201378. https:\/\/doi.org\/10.1016\/j.phymed.2015.12.003.","journal-title":"Phytomedicine"},{"issue":"10","key":"1872_CR70","first-page":"1289","volume":"39","author":"YN Dong","year":"2022","unstructured":"Dong YN, Guo BZ, Hou JJ, Yuan ZY, Tang YH, Yang J. Echinacoside inhibits the proliferation, invasion and stem cell-like properties of ovarian cancer SKOV3 cells. Chin J Mod Appl Pharm. 2022;39(10):1289\u201395.","journal-title":"Chin J Mod Appl Pharm"},{"issue":"12","key":"1872_CR71","doi-asserted-by":"publisher","first-page":"10216","DOI":"10.1002\/jcb.27363","volume":"119","author":"W Lim","year":"2018","unstructured":"Lim W, An Y, Yang C, Bazer FW, Song G. Chrysophanol induces cell death and inhibits invasiveness via mitochondrial calcium overload in ovarian cancer cells. J Cell Biochem. 2018;119(12):10216\u201327. https:\/\/doi.org\/10.1002\/jcb.27363.","journal-title":"J Cell Biochem"},{"key":"1872_CR72","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.colsurfa.2017.02.031","volume":"520","author":"Z Guo","year":"2017","unstructured":"Guo Z, Zhang T, Chen X, Fang K, Hou M, Gu N. The effects of porosity and stiffness of Genipin cross-linked egg white simulating aged extracellular matrix on proliferation and aggregation of ovarian cancer cells. Colloids Surf A Physicochem Eng Asp. 2017;520:649\u201360.","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"issue":"6","key":"1872_CR73","first-page":"709","volume":"32","author":"H Ma","year":"2010","unstructured":"Ma H, Fan Q. Progress in research on anticancer effect of Tanshinone \u2161A and its mechanisms both in vivo and in vitro. J Dalian Med Univ. 2010;32(6):709\u201312.","journal-title":"J Dalian Med Univ"},{"issue":"1","key":"1872_CR74","first-page":"65","volume":"39","author":"J Li","year":"2018","unstructured":"Li J, Wang A, Zhou T, Li T, Cai H, Liu A. CUEDC2 down-regulation enhanced sensitivity of ovarian carcinoma cells to cisplatin. Acad J Chin PLA Med Sch. 2018;39(1):65\u20136881.","journal-title":"Acad J Chin PLA Med Sch"},{"issue":"5","key":"1872_CR75","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3892\/or.2021.8027","volume":"45","author":"M Ji","year":"2021","unstructured":"Ji M, Li X, Liu J, et al. Curcumin inhibits the growth of granulosa cell tumor of the ovary by inducing apoptosis and targeting the MAPK and PI3K\/AKT pathways. Oncol Rep. 2021;45(5):76. https:\/\/doi.org\/10.3892\/or.2021.8027.","journal-title":"Oncol Rep"},{"issue":"1","key":"1872_CR76","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3892\/ijo.2015.3000","volume":"47","author":"L Li","year":"2015","unstructured":"Li L, Yue GG, Lau CB, et al. Oridonin induces apoptosis in ovarian cancer cells through the JNK\/p38 MAPK pathway. Int J Oncol. 2015;47(1):352\u201360. https:\/\/doi.org\/10.3892\/ijo.2015.3000.","journal-title":"Int J Oncol"},{"issue":"2","key":"1872_CR77","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1124\/pr.56.2.6","volume":"56","author":"G Minotti","year":"2004","unstructured":"Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev. 2004;56(2):185\u2013229. https:\/\/doi.org\/10.1124\/pr.56.2.6.","journal-title":"Pharmacol Rev"},{"issue":"4 Suppl 8","key":"1872_CR78","first-page":"23","volume":"23","author":"RT Dorr","year":"1996","unstructured":"Dorr RT. Cytoprotective agents for anthracyclines. Semin Oncol. 1996;23(4 Suppl 8):23\u201334.","journal-title":"Semin Oncol"},{"issue":"7","key":"1872_CR79","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/s0006-2952(98)00307-4","volume":"57","author":"DA Gewirtz","year":"1999","unstructured":"Gewirtz DA. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol. 1999;57(7):727\u201341. https:\/\/doi.org\/10.1016\/s0006-2952(98)00307-4.","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"1872_CR80","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1023\/a:1008365716693","volume":"11","author":"T Safra","year":"2000","unstructured":"Safra T, Muggia F, Jeffers S, et al. Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500\u00a0mg\/m2. Ann Oncol. 2000;11(8):1029\u201333. https:\/\/doi.org\/10.1023\/a:1008365716693.","journal-title":"Ann Oncol"},{"issue":"Suppl 4","key":"1872_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003495-199700544-00003","volume":"54","author":"GN Hortob\u00e1gyi","year":"1997","unstructured":"Hortob\u00e1gyi GN. Anthracyclines in the treatment of cancer. An overview. Drugs. 1997;54(Suppl 4):1\u20137. https:\/\/doi.org\/10.2165\/00003495-199700544-00003.","journal-title":"Drugs"},{"issue":"3","key":"1872_CR82","first-page":"139","volume":"135","author":"L Sun","year":"2017","unstructured":"Sun L, Wang Y, Zhang Y, et al. DMY sensitizes ovarian cancer cells to adriamycin by downregulating P-glycoprotein expression through the MAPK\/ERK pathway. J Pharmacol Sci. 2017;135(3):139\u201346.","journal-title":"J Pharmacol Sci"},{"issue":"5","key":"1872_CR83","first-page":"4923","volume":"18","author":"X Ma","year":"2019","unstructured":"Ma X, Chen H, Li Y, et al. Hydroxysafflor yellow A enhances chemosensitivity of ovarian cancer cells to doxorubicin through synergistic potentiation. Oncol Lett. 2019;18(5):4923\u201331.","journal-title":"Oncol Lett"},{"issue":"1","key":"1872_CR84","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1038\/s41467-023-37834-w","volume":"14","author":"Y Huang","year":"2023","unstructured":"Huang Y, Zhang J, Chen W, Wang X. Cisplatin-induced DNA crosslinking triggers replication fork stalling and Chk1-dependent cell cycle arrest. Nat Commun. 2023;14(1):2158. https:\/\/doi.org\/10.1038\/s41467-023-37834-w.","journal-title":"Nat Commun"},{"key":"1872_CR85","doi-asserted-by":"publisher","first-page":"102329","DOI":"10.1016\/j.redox.2022.102329","volume":"52","author":"L Zhang","year":"2022","unstructured":"Zhang L, Wang H, Li Q, Liu Z. ROS-mediated cisplatin resistance in cancer: mechanisms and targeting strategies. Redox Biol. 2022;52:102329. https:\/\/doi.org\/10.1016\/j.redox.2022.102329.","journal-title":"Redox Biol"},{"key":"1872_CR86","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Ovarian Cancer. Version 3.2023. Plymouth Meeting, PA: National Comprehensive Cancer Network. 2023. Available from: https:\/\/www.nccn.org"},{"key":"1872_CR87","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jconrel.2021.06.029","volume":"336","author":"SW Lee","year":"2021","unstructured":"Lee SW, Kim HS, Kim JY, Ahn JB. Enhanced antitumor efficacy of cisplatin combined with Paclitaxel through nanoparticle delivery in metastatic gastric cancer. J Control Release. 2021;336:260\u201373. https:\/\/doi.org\/10.1016\/j.jconrel.2021.06.029.","journal-title":"J Control Release"},{"issue":"1","key":"1872_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2867-10-16","volume":"10","author":"H Luo","year":"2010","unstructured":"Luo H, Daddysman MK, Rankin GO, Jiang BH, Chen YC. Kaempferol enhances cisplatin\u2019s effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc. Cancer Cell Int. 2010;10(1):16. https:\/\/doi.org\/10.1186\/1475-2867-10-16.","journal-title":"Cancer Cell Int"},{"issue":"23","key":"1872_CR89","doi-asserted-by":"publisher","first-page":"8910","DOI":"10.1158\/0008-5472.CAN-09-1543","volume":"69","author":"el-SA Arafa","year":"2009","unstructured":"Arafa el-SA, Zhu Q, Barakat BM, et al. Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase\/Akt signaling pathway. Cancer Res. 2009;69(23):8910\u20137. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1543.","journal-title":"Cancer Res"},{"issue":"2","key":"1872_CR90","doi-asserted-by":"publisher","first-page":"331","DOI":"10.31925\/farmacia.2019.2.19","volume":"67","author":"C Jin","year":"2019","unstructured":"Jin C, Ying J, Yang W, Liang R. Hydroxysafflor yellow A reverse chemotherapy resistance via JNK and P38 MAPK signal pathway in ovarian cancer cell. Farm\u00e1cia. 2019;67(2):331\u20136.","journal-title":"Farm\u00e1cia"},{"issue":"9","key":"1872_CR91","doi-asserted-by":"publisher","first-page":"7515","DOI":"10.1002\/jcb.27063","volume":"119","author":"I Hussain","year":"2018","unstructured":"Hussain I, Waheed S, Ahmad KA, Pirog JE, Syed V. Scutellaria baicalensis targets the hypoxia-inducible factor-1\u03b1 and enhances cisplatin efficacy in ovarian cancer. J Cell Biochem. 2018;119(9):7515\u201324. https:\/\/doi.org\/10.1002\/jcb.27063.","journal-title":"J Cell Biochem"},{"issue":"2","key":"1872_CR92","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00404-017-4580-9","volume":"297","author":"C Li","year":"2018","unstructured":"Li C, Hong L, Liu C, Min J, Hu M, Guo W. Astragalus polysaccharides increase the sensitivity of SKOV3 cells to cisplatin. Arch Gynecol Obstet. 2018;297(2):381\u20136. https:\/\/doi.org\/10.1007\/s00404-017-4580-9.","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"1872_CR93","first-page":"208","volume":"33","author":"W Li","year":"2018","unstructured":"Li W, Lv B, Qian J, Su L, Yang T, Qian J, et al. Effect of microRNA-150 on proliferation, apoptosis, invasion and metastasis of epithelial ovarian cancer cells. Pract Oncol J. 2018;33(3):208\u201313.","journal-title":"Pract Oncol J"},{"issue":"19","key":"1872_CR94","doi-asserted-by":"publisher","first-page":"eabm4541","DOI":"10.1126\/sciadv.abm4541","volume":"8","author":"Q Wei","year":"2022","unstructured":"Wei Q, Zhang F, Li J. Structural insights into paclitaxel-induced microtubule stabilization. Sci Adv. 2022;8(19):eabm4541. https:\/\/doi.org\/10.1126\/sciadv.abm4541.","journal-title":"Sci Adv"},{"issue":"7","key":"1872_CR95","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1158\/0008-5472.CAN-22-2876","volume":"83","author":"L Zhang","year":"2023","unstructured":"Zhang L, Li W. Paclitaxel-induced apoptosis mechanisms in solid tumors. Cancer Res. 2023;83(7):1021\u201333. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-2876.","journal-title":"Cancer Res"},{"issue":"6","key":"1872_CR96","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s43018-023-00542-9","volume":"4","author":"D Fukumura","year":"2023","unstructured":"Fukumura D, Kloepper J, Jain RK. Tumor vascular normalization as a mechanistic biomarker of Paclitaxel efficacy. Nat Cancer. 2023;4(6):789\u2013802. https:\/\/doi.org\/10.1038\/s43018-023-00542-9.","journal-title":"Nat Cancer"},{"issue":"1","key":"1872_CR97","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41397-023-00301-2","volume":"23","author":"RW Johnson","year":"2023","unstructured":"Johnson RW, Patel SK, McLeod HL. CYP2C8 polymorphisms and Paclitaxel metabolism: A genome-wide association study. Pharmacogenomics J. 2023;23(1):45\u201353. https:\/\/doi.org\/10.1038\/s41397-023-00301-2.","journal-title":"Pharmacogenomics J"},{"issue":"11","key":"1872_CR98","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s40262-021-01086-8","volume":"60","author":"MV Relling","year":"2021","unstructured":"Relling MV, Gardner EE. Pharmacogenetics of taxanes (paclitaxel, docetaxel) and camptothecins (irinotecan, topotecan). Clin Pharmacokinet. 2021;60(11):1467\u201384. https:\/\/doi.org\/10.1007\/s40262-021-01086-8.","journal-title":"Clin Pharmacokinet"},{"issue":"5S","key":"1872_CR99","doi-asserted-by":"publisher","first-page":"691","DOI":"10.6004\/jnccn.2022.0030","volume":"20","author":"WJ Gradishar","year":"2022","unstructured":"Gradishar WJ, Moran MS, Abraham J. NCCN Guidelines\u00ae updates: breast cancer. J Natl Compr Canc Netw. 2022;20(5S):691\u20134.","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"1872_CR100","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S1470-2045(23)00312-5","volume":"24","author":"Ovarian Cancer Consortium","year":"2023","unstructured":"Ovarian Cancer Consortium. Platinum-taxane sequencing in advanced ovarian cancer: final survival analysis of the PROCTOR trial. Lancet Oncol. 2023;24(8):899\u2013911. https:\/\/doi.org\/10.1016\/S1470-2045(23)00312-5.","journal-title":"Lancet Oncol"},{"issue":"15","key":"1872_CR101","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1200\/JCO.22.02567","volume":"41","author":"X Chen","year":"2023","unstructured":"Chen X, Wang Y, Liu H. Anthracycline-paclitaxel combinations in breast cancer: A systematic review and meta-analysis. J Clin Oncol. 2023;41(15):2789\u2013801. https:\/\/doi.org\/10.1200\/JCO.22.02567.","journal-title":"J Clin Oncol"},{"issue":"10","key":"1872_CR102","first-page":"1003","volume":"48","author":"S Lin","year":"2020","unstructured":"Lin S, Gao J. Progress in the effect of flavonoids on drug resistance in ovarian cancer. Tianjin Med J. 2020;48(10):1003\u20138.","journal-title":"Tianjin Med J"},{"issue":"6","key":"1872_CR103","doi-asserted-by":"publisher","first-page":"9561","DOI":"10.1002\/jcb.28296","volume":"120","author":"SS Lin","year":"2019","unstructured":"Lin SS, Lai YJ, Huang SM, et al. Curcumin suppresses proliferation and induces apoptosis of human ovarian cancer cells via MAPK and PI3K\/Akt pathways. J Cell Biochem. 2019;120(6):9561\u20139. https:\/\/doi.org\/10.1002\/jcb.28296.","journal-title":"J Cell Biochem"},{"issue":"11","key":"1872_CR104","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.2174\/138161213805289219","volume":"19","author":"MM Yallapu","year":"2013","unstructured":"Yallapu MM, Jaggi M, Chauhan SC. Curcumin nanomedicine: a road to cancer therapeutics. Curr Pharm Des. 2013;19(11):1994\u20132010. https:\/\/doi.org\/10.2174\/138161213805289219.","journal-title":"Curr Pharm Des"},{"key":"1872_CR105","doi-asserted-by":"publisher","first-page":"689372","DOI":"10.3389\/fphar.2021.689372","volume":"12","author":"J Chen","year":"2021","unstructured":"Chen J, Wang Y, Zhang Y, et al. Baicalein enhances cisplatin sensitivity in ovarian cancer cells by regulating the MAPK\/ERK pathway. Front Pharmacol. 2021;12:689372. https:\/\/doi.org\/10.3389\/fphar.2021.689372.","journal-title":"Front Pharmacol"},{"issue":"15","key":"1872_CR106","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1089\/ars.2017.7410","volume":"29","author":"CZ Wang","year":"2018","unstructured":"Wang CZ, Calway TD, Du GJ, et al. Baicalein modulates mitochondrial dysfunction and oxidative stress via the MAPK signaling pathway in cancer. Antioxid Redox Signal. 2018;29(15):1539\u201355. https:\/\/doi.org\/10.1089\/ars.2017.7410.","journal-title":"Antioxid Redox Signal"},{"issue":"10","key":"1872_CR107","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.3390\/cancers12102965","volume":"12","author":"T Liu","year":"2020","unstructured":"Liu T, Li P, Wang G, et al. Ginsenoside Rg3 targets cancer-associated fibroblasts to inhibit angiogenesis in ovarian cancer via MAPK\/AP-1\/VEGF signaling. Cancers (Basel). 2020;12(10):2965. https:\/\/doi.org\/10.3390\/cancers12102965.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"1872_CR108","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1038\/s41416-021-01262-6","volume":"124","author":"ZL Zhou","year":"2021","unstructured":"Zhou ZL, Yang YX, Ding J, et al. Triptolide disrupts the TAK1-JNK\/p38-NF-\u03baB axis to suppress ovarian cancer progression. Br J Cancer. 2021;124(8):1420\u201332. https:\/\/doi.org\/10.1038\/s41416-021-01262-6.","journal-title":"Br J Cancer"},{"issue":"15","key":"1872_CR109","doi-asserted-by":"publisher","first-page":"7102","DOI":"10.1021\/acs.jmedchem.9b00588","volume":"62","author":"Q Liu","year":"2019","unstructured":"Liu Q, Wang Y, Liu L, et al. Targeting cancer stem cells by triptolide prodrugs for improved ovarian cancer therapy. J Med Chem. 2019;62(15):7102\u201315. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b00588.","journal-title":"J Med Chem"},{"issue":"11","key":"1872_CR110","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1002\/ptr.6723","volume":"34","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Zhao Y, Hashemzaei M, et al. Quercetin targets MAPK\/STAT3\/Snail signaling to inhibit ovarian cancer cell invasion and metastasis. Phytother Res. 2020;34(11):2932\u201344. https:\/\/doi.org\/10.1002\/ptr.6723.","journal-title":"Phytother Res"},{"key":"1872_CR111","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.freeradbiomed.2021.12.004","volume":"178","author":"Y Li","year":"2022","unstructured":"Li Y, He J, Sui H, et al. ROS-mediated MAPK\/autophagy signaling modulates quercetin-induced apoptosis in ovarian cancer cells. Free Radic Biol Med. 2022;178:246\u201358. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.12.004.","journal-title":"Free Radic Biol Med"},{"key":"1872_CR112","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.canlet.2021.07.027","volume":"520","author":"F Guan","year":"2021","unstructured":"Guan F, Li G, Liu AB, et al. Curcumin synergizes with Paclitaxel to inhibit ovarian cancer growth by regulating the MAPK\/ERK and NF-\u03baB signaling pathways. Cancer Lett. 2021;520:231\u201342. https:\/\/doi.org\/10.1016\/j.canlet.2021.07.027.","journal-title":"Cancer Lett"},{"issue":"5","key":"1872_CR113","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1039\/D1BM01785E","volume":"10","author":"MK Sundaram","year":"2022","unstructured":"Sundaram MK, Preetha R, Pandey R, et al. Nano-curcumin and Paclitaxel co-target the PI3K\/AKT\/mTOR and MAPK\/ERK pathways to suppress the proliferation and induce apoptosis in ovarian cancer cells. Biomater Sci. 2022;10(5):1245\u201358. https:\/\/doi.org\/10.1039\/D1BM01785E.","journal-title":"Biomater Sci"},{"key":"1872_CR114","doi-asserted-by":"publisher","first-page":"567982","DOI":"10.3389\/fonc.2020.567982","volume":"10","author":"X Li","year":"2020","unstructured":"Li X, Zhou R, Liu X, et al. Baicalein reverses cisplatin resistance in ovarian cancer by inhibiting the MAPK\/ERK signaling pathway and suppressing DNA repair. Front Oncol. 2020;10:567982. https:\/\/doi.org\/10.3389\/fonc.2020.567982.","journal-title":"Front Oncol"},{"key":"1872_CR115","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jconrel.2023.01.032","volume":"354","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Li W, Wang J, et al. Co-delivery of Baicalein and cisplatin via a liposomal platform for enhanced synergistic therapy of ovarian cancer by regulating the MAPK-mediated apoptotic pathway. J Control Release. 2023;354:654\u201367. https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.032.","journal-title":"J Control Release"},{"key":"1872_CR116","doi-asserted-by":"publisher","first-page":"105891","DOI":"10.1016\/j.phrs.2021.105891","volume":"173","author":"J Wang","year":"2021","unstructured":"Wang J, Li Y, Zhang Y, et al. Ginsenoside Rg3 enhances the antitumor effect of Olaparib in BRCA-mutated ovarian cancer by inhibiting the MAPK\/ERK signaling pathway and angiogenesis. Pharmacol Res. 2021;173:105891. https:\/\/doi.org\/10.1016\/j.phrs.2021.105891.","journal-title":"Pharmacol Res"},{"issue":"1","key":"1872_CR117","doi-asserted-by":"publisher","first-page":"18376","DOI":"10.1038\/s41598-019-54899-0","volume":"9","author":"HS Kim","year":"2019","unstructured":"Kim HS, Lee JK, Lee KT, et al. Korean red ginseng extract enhances the anticancer effects of PARP inhibitors via JNK activation in ovarian cancer. Sci Rep. 2019;9(1):18376. https:\/\/doi.org\/10.1038\/s41598-019-54899-0.","journal-title":"Sci Rep"},{"issue":"14","key":"1872_CR118","first-page":"2691","volume":"82","author":"S Yang","year":"2022","unstructured":"Yang S, et al. Triptolide sensitizes carboplatin in ovarian cancer via TAK1-MAPK\/NF-\u03baB axis disruption. Cancer Res. 2022;82(14):2691\u2013705.","journal-title":"Cancer Res"},{"issue":"8","key":"1872_CR119","doi-asserted-by":"crossref","first-page":"10187","DOI":"10.1021\/acsnano.0c03457","volume":"14","author":"H Xu","year":"2020","unstructured":"Xu H, et al. PEGylated triptolide co-loaded with carboplatin enhances ovarian cancer therapy through ROS-MAPK synergy. ACS Nano. 2020;14(8):10187\u2013201.","journal-title":"ACS Nano"},{"issue":"8","key":"1872_CR120","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1158\/1535-7163.MCT-20-0937","volume":"20","author":"Y Cao","year":"2021","unstructured":"Cao Y, Wang L, Li J, et al. Resveratrol enhances docetaxel-induced growth Inhibition and apoptosis in ovarian cancer cells by suppressing epithelial-mesenchymal transition via the MAPK signaling pathway. Mol Cancer Ther. 2021;20(8):1435\u201346. https:\/\/doi.org\/10.1158\/1535-7163.MCT-20-0937.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"1872_CR121","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12951-023-01805-5","volume":"21","author":"AP Singh","year":"2023","unstructured":"Singh AP, Malla R, Li X, et al. Nano-resveratrol and taxanes co-target the MAPK\/autophagy signaling axis to inhibit ovarian cancer metastasis. J Nanobiotechnol. 2023;21(1):45. https:\/\/doi.org\/10.1186\/s12951-023-01805-5.","journal-title":"J Nanobiotechnol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01872-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01872-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01872-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T11:49:29Z","timestamp":1772452169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-025-01872-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":121,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1872"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01872-3","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors gave the consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}